Overview

Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of AFQ056 and nicotine compared to placebo on craving and withdrawal symptoms during voluntary smoking stoppage in healthy smokers. This study will also assess how the body interacts with AFQ056.
Phase:
Phase 1
Details
Lead Sponsor:
Novartis
Treatments:
Nicotine